A patient has a serum phosphate level of 2.0 mg/dL. Which treatments should the nurse expect to be prescribed for this patient? Select all that apply.
Normal saline.
Potassium phosphate.
Additional milk intake.
Increased Vitamin D intake.
Correct Answer : B,C,D
The correct answers are Choices B, C, and D.
Choice A rationale: Normal saline is not typically used to treat low phosphate levels. It is often used to treat dehydration and electrolyte imbalances that do not include hypophosphatemia.
Choice B rationale: Potassium phosphate is used to treat low phosphate levels. It directly supplements phosphate levels in the body, making it an appropriate treatment for hypophosphatemia.
Choice C rationale: Additional milk intake can help increase phosphate levels, as milk is a good source of phosphate. This is a suitable recommendation for a patient with low phosphate levels.
Choice D rationale: Increased Vitamin D intake can enhance phosphate absorption from the gastrointestinal tract, making it a beneficial treatment for a patient with low phosphate levels.
Nursing Test Bank
Naxlex Comprehensive Predictor Exams
Related Questions
Correct Answer is D
Explanation
25 mg/dL.
Choice A rationale:
A BUN (Blood Urea Nitrogen) level of 10 mg/dL is within the normal range, indicating normal kidney function. There is no indication to report this value to the provider for a dehydrated client.
Choice B rationale:
A BUN level of 18 mg/dL is within the normal range as well. This value does not suggest significant dehydration, so it is not necessary to report it to the provider in this context.
Choice C rationale:
A BUN level of 13 mg/dL is also within the normal range, and similar to choices A and B, it does not indicate severe dehydration that requires immediate reporting to the provider.
Choice D rationale:
A BUN level of 25 mg/dL is elevated, which may indicate dehydration, kidney dysfunction, or other issues affecting fluid balance. Since the client is dehydrated, this elevated value needs to be reported to the provider for further evaluation and appropriate intervention.
Correct Answer is D
Explanation
The correct answer is choice D: Reduction of T-wave amplitude.
Choice A rationale:
The amplitude of the QRS complex is not directly affected by changes in serum potassium levels. It represents ventricular depolarization, and its restoration would not be an expected outcome of polystyrene sulfonate treatment
Choice B rationale:
Shortening of the P-wave duration is not an expected change with polystyrene sulfonate treatment. The P-wave represents atrial depolarization, which is not significantly impacted by the administration of this medication
Choice C rationale:
Widening of the QRS complex is associated with high serum potassium levels. The goal of polystyrene sulfonate treatment is to lower potassium levels and, thus, return the QRS complex to its normal width
Choice D rationale:
Polystyrene sulfonate aims to reduce serum potassium levels. When effective, this should result in a reduction of T-wave amplitude, which is a common ECG change seen with hyperkalemia
In conclusion, choice D is the correct answer, as a reduction in T-wave amplitude would be the expected change on the client's ECG if polystyrene sulfonate effectively lowers their serum potassium level.
Whether you are a student looking to ace your exams or a practicing nurse seeking to enhance your expertise , our nursing education contents will empower you with the confidence and competence to make a difference in the lives of patients and become a respected leader in the healthcare field.
Visit Naxlex, invest in your future and unlock endless possibilities with our unparalleled nursing education contents today
Report Wrong Answer on the Current Question
Do you disagree with the answer? If yes, what is your expected answer? Explain.
Kindly be descriptive with the issue you are facing.